Skip to main content
. 2021 Aug;10(4):434–442. doi: 10.21037/hbsn-21-188

Table 4. Safety summary.

AEs Any grade, n (%) Grade 3, n (%)
Fatigue 6 (66.7) 1 (11.1)
Hypertension 5 (55.6) 2 (22.2)
ALT or AST elevation 6 (66.7) 0 (0.0)
Hypothyroidism 1 (11.1) 0 (0.0)
Decreased appetite 5 (55.6) 1 (11.1)
Abdominal pain 1 (11.1) 0 (0.0)
Vomiting 2 (22.2) 0 (0.0)
Skin rash 3 (33.3) 1 (11.1)
Anaemia 1 (11.1) 0 (0.0)
Diarrhoea 1 (11.1) 0 (0.0)
Hand-foot syndrome 2 (22.2) 0 (0.0)
Leukocytopenia 2 (22.2) 1 (11.1)
Nasal haemorrhage 4 (44.4) 1 (11.1)
Asthma 1 (11.1) 1 (11.1)

AEs, adverse events; ALT, alanine aminotransferase; AST, aspartate aminotransferase.